2Connell JM, MacKenzie SM, Freel EM, et al. A lifetime ofaldosterone excess: Long-term consequences of altered regulation of aldosterone production for cardlovsscular function[J]. Endocr Rev,2008,29(2) :133-154.
3Zhao G, Ford ES, Li C. Associations of serum concentrations of 25-hydroxyvitamin D and parathyroid hormone with surrogate markers of insulin resistance among U. S. adults without physician-diagnosed diabetes: NHANES, 2003 - 2006 [J].Diabetes Care,2010,33(2) :344-347.
4Kamen DL, Tangpricha V. Vitamin D and molecular actions the immune system: modulation of innate and autoimmunity[J]. J Mol Med(Berl) ,2010,88(5) :441-450.
5Khazai N, Judd SE, Tangpricha V. Calcium and vitamin D: skeletal and extraskeletal health[J]. Curr Rheumatol Rep, 2008 ,10(2) :110-117.
6Liu E, Meigs JB, Pittas AG, et al. Predicted 25-hydrox- yvitamin D score and incident type 2 diabetes in the Framingham Offspring Study[J].Am J Clin Nutr , 2010,91 (6) : 1627-1633.
7Kayaniyil S, Vieth R, Retnakaran R, at al. Association of vitamin D with insulin resistance and :3-eell dysfunction in subjects at risk for type 2 diabetes[J].Diabetes Care,2010,33 (6) : 1379-1381.
8von Hurst PR, Stonehouse W, Coad J. Vitamin D supple- mentation reduces insulin resistance in South Asian women living in New Zealand who are insulin resistant and vitamin D deficient-a randomised, placebo-controlled trial [J].Br J Nutr, 2010,103(4) :549-555.
9Gulseth HL, Gjelstad IM, Tierney AC,at al. Serum vitamin D concentration does not predict insulin action or secretion in European subiects with the metabolic syndrome[J]. Diabetes Care,20!0, 33(4) :923-925.
10Ganji V, Zhang X, Shaikh N,at al. Serum 25-hydroxyvitamin D concentrations are associated with prevalence of metabolic syndrome and various cardiometabolic risk factors in US children and adolescents based on assay-adiusted serum 25 hydroxyvitamin D data from NHANES 2001-2006[J]. Am J Clin Nutr,2011, 94(1) :225-233.
